Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- Check5 days agoChange DetectedAdded the page revision tag Revision: v3.6.2 and removed Revision: v3.6.0, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew sections/links were added: How to Read a Study Record, Common Questions, and How to Join a Study, and the page now states 'No longer looking for participants' to indicate recruitment has ended. The label for the Intervention/Treatment section was adjusted from 'Intervention / Treatment' and the page footer shows 'Revision: v3.6.0'.SummaryDifference0.6%

- Check26 days agoChange DetectedA minor revision update was applied to the site, updating the revision tag from v3.5.4 to v3.5.5, signaling a small behind-the-scenes update.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor maintenance release rather than a substantive update to content or features.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision label on the page was updated to v3.5.3, replacing the prior v3.5.2, which reflects a new build of the page.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.